Literature DB >> 15608631

Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.

H Christian Peters1, Hua Hu, Olaf Pongs, Johan F Storm, Dirk Isbrandt.   

Abstract

In humans, mutations in the KCNQ2 or KCNQ3 potassium-channel genes are associated with an inherited epilepsy syndrome. We have studied the contribution of KCNQ/M-channels to the control of neuronal excitability by using transgenic mice that conditionally express dominant-negative KCNQ2 subunits in brain. We show that suppression of the neuronal M current in mice is associated with spontaneous seizures, behavioral hyperactivity and morphological changes in the hippocampus. Restriction of transgene expression to defined developmental periods revealed that M-channel activity is critical to the development of normal hippocampal morphology during the first postnatal weeks. Suppression of the M current after this critical period resulted in mice with signs of increased neuronal excitability and deficits in hippocampus-dependent spatial memory. M-current-deficient hippocampal CA1 pyramidal neurons showed increased excitability, reduced spike-frequency adaptation, attenuated medium afterhyperpolarization and reduced intrinsic subthreshold theta resonance. M channels are thus critical determinants of cellular and neuronal network excitability, postnatal brain development and cognitive performance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15608631     DOI: 10.1038/nn1375

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  178 in total

1.  The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.

Authors:  Anastassios V Tzingounis; Matthias Heidenreich; Tatjana Kharkovets; Guillermo Spitzmaul; Henrik S Jensen; Roger A Nicoll; Thomas J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

2.  A novel degradation signal derived from distal C-terminal frameshift mutations of KCNQ2 protein which cause neonatal epilepsy.

Authors:  Jun Su; Xu Cao; KeWei Wang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation.

Authors:  Anastasia Kosenko; Seungwoo Kang; Ida M Smith; Derek L Greene; Lorene K Langeberg; John D Scott; Naoto Hoshi
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

Review 4.  KCNQ potassium channels in sensory system and neural circuits.

Authors:  Jing-jing Wang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

Review 5.  Electrical resonance with voltage-gated ion channels: perspectives from biophysical mechanisms and neural electrophysiology.

Authors:  Lin Ge; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

6.  Kv7.2 regulates the function of peripheral sensory neurons.

Authors:  Chih H King; Eric Lancaster; Daniela Salomon; Elior Peles; Steven S Scherer
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

Review 7.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 8.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

9.  Activity-dependent transcriptional regulation of M-Type (Kv7) K(+) channels by AKAP79/150-mediated NFAT actions.

Authors:  Jie Zhang; Mark S Shapiro
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

Review 10.  Neural KCNQ (Kv7) channels.

Authors:  David A Brown; Gayle M Passmore
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.